Retraction notice to "Pigment epithelium-derived factor inhibits erythropoietin-induced retinal endothelial cell angiogenesis by suppression of PI3K/Akt pathway" [Experimental Eye Research 90 (2010) 726-733];Pigment epithelium-derived factor inhibits erythropoietin-induced retinal endothelial cell angiogenesis by suppression of PI3K/Akt pathway

Experimental Eye Research

Volumn 90, Issue 6, 2010, Pages 726-733

  Haribalaganesh, Ravinarayanan ^a   Sheikpranbabu, Sardarpasha ^a   Banumathi, Elayappan ^a   Gurunathan, Sangiliyandi ^a  

^a KALASALINGAM UNIVERSITY   (India)

Author keywords

Endothelial cells; Erythropoietin; Pigment epithelium derived factor; Proliferation; Vascular permeability

Indexed keywords

ERYTHROPOIETIN; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN KINASE B; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANGIOGENESIS INHIBITOR; CHROMONE DERIVATIVE; DEXTRAN; ENZYME INHIBITOR; EYE PROTEIN; MORPHOLINE DERIVATIVE; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HORMONE ACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RETINA CELL; ANIMAL; CAPILLARY PERMEABILITY; CELL MOTION; CULTURE TECHNIQUE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; GOAT; METABOLISM; RETINA BLOOD VESSEL; RETINA NEOVASCULARIZATION; VASCULAR ENDOTHELIUM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOGENESIS INHIBITORS; ANIMALS; CAPILLARY PERMEABILITY; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL PROLIFERATION; CHROMONES; DEXTRANS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; EYE PROTEINS; GOATS; MORPHOLINES; NERVE GROWTH FACTORS; PROTO-ONCOGENE PROTEINS C-AKT; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; SERPINS; TRANSFECTION;

EID: 77952755053     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.11.021     Document Type: Erratum

References (37)

1. Banumathi E., Haribalaganesh R., Sheik Pran Babu S., Kyung J.L., Sangiliyandi G. PEDF inhibits VEGF- and EPO-induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation. Angiogenesis 2009, 12:313-324.
2. Bilak M.M., Corse A.M., Bilak S.R., Lehar M., Tombran T.J., Kuncl R.W. Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J. Neuropathol. Exp. Neurol. 1999, 58:719-728.
3. Böcker-Meffert S., Rosenstiel P., Röhl C., Warneke N., Held-Feindt J., Sievers J., Lucius R. Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. Invest. Ophthalmol. Vis. Sci. 2002, 43:2021-2026.
4. Campochiaro A.P., Nguyen D.Q., Shah S.M., Klein L.M., Holz E., Frank N.R., Saperstein A.D., Gupta A., Stout T.J., Macko J., Dibartolomeo R., Wei L.L. Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum. Gene Ther. 2006, 17:167-176.
5. Daisuke W., Kiyoshi S., Shigeyuki M., Masafumi K., Junichi K., Mihori K., Izumi S., Hirokazu O., Tomonari O., Tomoaki M., Toshihiro K., Seiji M., Masaya N., Nagahisa Y., Hitoshi T. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N. Engl. J. Med. 2005, 353:782-792.
6. Dawson D.W., Volpert O.V., Gillis P., Crawford S.E., Xu H.J., Benedict W., Bouck N.P. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999, 285:245-248.
7. Domenico R., Marco P., Angelo V., Roberto R., Roberta G., Patrizia D., Beatrice N., Luisa R., Franco D. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999, 93:2627-2636.
8. Dolores L.M., Maaza G.A., Dilip K.D., Leonidas C.P., Shahab U., Amittha W. Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells. Oncogene 2002, 21:1556-1562.
9. Frank R.N. On the pathogenesis of diabetic retinopathy. Ophthalmology 1991, 98:586-593.
10. Galeano M., Altavilla D., Cucinotta D., Russo G.T., Calo M., Bitto A., Marini H., Marini R., Adamo B.E., Seminara P., Minutoli L., Torre V., Squadrito F. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 2004, 53:2509-2517.
11. Gerald M.Y., Quan J.O., Yaping L., Vicky K., Hong Z., Peter F.M.C. Localization of pigment epithelium-derived factor in growing mouse bone. Calcif. Tissue Int. 2005, 76:146-153.
12. Haribalaganesh, R., Sheikpranbabu, S., Elayappan, B., Venkataraman, D., Gurunathan, S., 2009. Pigment epithelium-derived factor down regulates hyperglycemia-induced apoptosis via PI3K/Akt activation in goat retinal pericytes.
13. Hugo H.M., Roland H.W., Luis A.R., Urs S., Murat O., Volker H., Yasuhiro Y., Christian B., Max G. Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 2006, 8:666-676.
14. Jelkmann W., Metzen E. Erythropoietin in the control of red cell production. Anat. Anz. 1996, 178:391-403.
15. Joyce T.T., Krzysztof M., Ignacio R.R., Daniel C., Timothy L., Ella E., Gerald J.C. Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol. Vis. 1996, 2:11.
16. Juul Sandra E., Anderson Douglas K., Li Yan, Christensen Robert D. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr. Res. 1998, 43:40-49.
17. Kayako M., Nahoko O., Masato M., Chieko S., Mitsumasa W., Nobuo J., Miyo M. Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy. Mol. Vis. 2008, 14:992-996.
18. Koury M.J., Bondurant M.C. The molecular mechanism of erythropoietin action. Eur. J. Biochem. 1992, 210:649-663.
19. Kuncl R.W., Bilak M.M., Bilak S.R., Corse A.M., Roya I.W., Becerra S.P. Pigment epithelium-derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis. J. Neurochem 2002, 81:178-184.
20. Leiling C., Samuel S.M.Z., Colin J.B., Joyce T.T. PEDF induces apoptosis in human endothelial cells by activating p38 MAP kinase dependent cleavage of multiple caspases. Biochem. Biophys. Res. Commun. 2006, 348:1288-1295.
21. Mary A.M., Xiaoming Z., Jing T., Claire Z., Apoorva S., Brett H., Carrie P. Straub scratching below the surface: wound healing and alanine mutagenesis provide unique insights into interactions between eristostatin, platelets and melanoma cells. Pathophysiol. Haemost. Thromb. 2005, 34:164-168.
22. Mori K., Gehlbach P., Yamamoto S., Duh E., Zack D.J., Li Q., Berns I.K., Raisler J.B., Hauswirth W.W., Campochiaro A.P. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 2002, 43:1994-2000.
23. Nahoko O., Maki N., Tetsuya N., Yumiko M., Miyo M. Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Am. J. Ophthalmol. 2002, 133:851-852.
24. Olga V.V., Tetiana Z., Wei Z., Frank R., Thomas A.F., Michael S.P., Mohammad A., Noel P.B. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium derived factor. Nat. Med. 2002, 8:349-357.
25. L. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H2467-H2474.
26. Raul G.C., Alvaro A.R., Marcos R. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int. 1995, 47:740-745.
27. Ray G.F., Thomas W.G. Retinal angiogenesis in development and disease. Nature 2005, 438:960-966.
28. Sarah M., Jacobs H., Kalyani P., Zhenhong S., Amy L., Stephen T.S. Distinct signaling from stem cell factor and erythropoietin in HCD57 cells. J. Biol. Chem. 1997, 272:6850-6853.
29. Sawant S., Aparicio S., Tink A.R., Lara N., Barnstable C.J., Tombran T.J. Regulation of factors controlling angiogenesis in liver development: a role for PEDF in the formation and maintenance of normal vasculature. Biochem. Biophys. Res. Commun. 2004, 325:408-413.
30. Semkova I., Kreppel F., Welsandt G., Luther T., Kozlowski J., Janicki H., Kochanek S., Shraermeyer U. Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye. Proc. Natl. Acad. Sci. 2002, 99:13090-13095.
31. Sheikpranbabu S., Haribalaganesh R., Banumathi E., Sirishkumar N., Jin Lee K., Gurunathan S. Pigment epithelium-derived factor inhibits advance glycation end-product-induced angiogenesis and stimulates apoptosis in retinal endothelial cells. Life Sci. 2009, 85:719-731.
32. Sheikpranbabu S., Kalishwaralal K., Venkataraman D., Eom S.H., Park J., Gurunathan S. Silver nanoparticles inhibit VEGF-and IL-1beta-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells. J. Nanobiotechnol. 2009, 7:8.
33. Steen V.P., Zuzana V., Jan J.E. Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization. Biochem. J. 2003, 374:199-206.
34. Tombran T.J., Johnson L.V. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest. Ophthalmol. Vis. Sci. 1989, 30:1700-1707.
35. Veronica S., Susan E.C., Wei Z., Noël B. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc. Natl. Acad. Sci. 2001, 98:2593-2597.
36. Xi-yuan Z., Qing L., Yi-min P., Yong-qiang T., Xiao G., Jia L.I., Yan X.U., Zhi-gang W. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization. Chin. Med. J. 2009, 122:2711-2717.
37. Yoshiya K., Tadashi O., Kazuhisa M., Masahiro O., Masahiko K., Toshiya W., Yoshiki I., Masayuki N., Hiroshi K., Hideo N., Takeshi M. Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Diabetes Care 2005, 28:2252-2254.